Product Pipeline

TC BioPharm is a biotechnology company developing a platform of CAR-T immuno-oncology products which build upon GDT cells to formulate treatments for a wide variety of hematological and solid tumor types. The product pipeline is centred around “off the shelf” GDT products.  We expand and engineer the GDT cells to target specific diseases.


We are creating groundbreaking, pioneering, disruptive therapies with unrivalled applicability to a broad range of cancers.  This step-changing approach leverages the immense therapeutic and commercial potential of GDT cells by ‘pharmaceuticalizing’ cell therapy, simplifying its ease of use, widening patient access and improving Quality of Life.